Copyright © 2026 Knight Sac Media. All rights reserved.https://www.siliconinvestor.com/subject.aspx?subjectid=8598 This company if focused on HIV related research. The stock price is low, indicative of a start-up company.Their scientists are collaborating with very reputable institutions and their objective is an effective Aids vaccine. This is possibly a worthwhile longshot @< 30 cents CDN. Website is <http//:www.stockgroup.com/imm.html>. (VSE:INI) Dan Byrnehttps://www.siliconinvestor.com/images/Logo380x132.pnghttps://www.siliconinvestor.com/subject.aspx?subjectid=859838013210